Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

This comprehensive e-book from The Hindu explores how gene editing tools like CRISPR and synthetic biology are fundamentally changing what it means to be human and are giving us the power to modify ...

The Global 3D Cell Culture Market is poised for strong double-digit growth by 2027, driven by rapid advancements in biotechnology, growing interest in advanced disease models, and a rising need for ...

In 2001, chemists K. Barry Sharpless, Hartmuth C. Kolb, and M. G. Finn introduced click chemistry, a concept in which organic ...

Nerve fibers in the brain and spinal cord are wrapped in an insulating sheath known as myelin. For a long time, this barrier, ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being addressed to enhance the safety, durability and efficacy of RNA therapeutics.

Optimally positioning CD19-directed therapies in the follicular lymphoma treatment sequence requires consideration of both ...

Recent advances in the treatment of non-small cell lung cancer (NSCLC) have led to improved patient outcomes, particularly ...

This video provides a comprehensive flight review of TAP Air Portugal, showcasing both Economy and Business classes on the ...

The global biotechnology market is projected to reach over $4 trillion by 2035; the GCC market is expected to reach $2.6 ...

The advent of chimeric antigen receptor (CAR)-T cell therapy has marked the onset of a very promising option to treat solid tumors after its remarkable ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...